Literature DB >> 7831771

Single cell transcript analysis of human immunodeficiency virus gene expression in the transition from latent to productive infection.

H Peng1, T A Reinhart, E F Retzel, K A Staskus, M Zupancic, A T Haase.   

Abstract

In the lymph nodes of individuals infected with human immunodeficiency virus (HIV), there is evidence that points to three kinds of virus-cell relationships. Virions may be associated with CD4+ lymphocytes that are actively producing virus or may be bound at the surfaces of follicular dendritic cells like other antigens. HIV is also harbored in CD4+ lymphocytes and monocytes/macrophages in a latent form as transcriptionally silenced provirus. To ultimately investigate in vivo these and other HIV-cell interactions that play such critical roles in the persistence of virus, immune dysregulation, and depletion, we have developed an in situ hybridization method that discriminates multiply spliced from singly or unspliced viral transcripts. In this report we describe the method and the results obtained with it in an analysis of the switch from latent to productive infection of chronically infected T lymphocytes in culture. We found with this single-cell technique that there are two subpopulations in the culture, a minor one of productively infected cells and a major one of latently infected cells in which only low levels of viral transcripts terminated close to the 5' end of the viral genome were detected. Shortly after activation of viral gene expression with phorbol ester, transcripts encoding Tat and Rev increase in abundancy in individual latently infected cells and this is followed by increases in and cytoplasmic export of singly or unspliced mRNAs encoding structural proteins. These studies provide insights into the regulation of HIV gene expression from a single-cell perspective and, from that perspective, transcript profiles of productively infected cells as a frame of reference for defining HIV-cell relationships in individual cells in tissue sections.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7831771     DOI: 10.1016/s0042-6822(95)80015-8

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

Review 1.  Role of dendritic cells in immunopathogenesis of human immunodeficiency virus infection.

Authors:  D Weissman; A S Fauci
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

2.  Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo.

Authors:  P Bagnarelli; A Valenza; S Menzo; R Sampaolesi; P E Varaldo; L Butini; M Montroni; C F Perno; S Aquaro; D Mathez; J Leibowitch; C Balotta; M Clementi
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

3.  RNA-mediated TILDA for improved cell capacity and enhanced detection of multiply-spliced HIV RNA.

Authors:  Hannah M Pezzi; Scott M Berry; David J Beebe; Rob Striker
Journal:  Integr Biol (Camb)       Date:  2017-11-13       Impact factor: 2.192

4.  Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure.

Authors:  J K Wong; H F Günthard; D V Havlir; Z Q Zhang; A T Haase; C C Ignacio; S Kwok; E Emini; D D Richman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

5.  RNA-targeted activators, but not DNA-targeted activators, repress the synthesis of short transcripts at the human immunodeficiency virus type 1 long terminal repeat.

Authors:  P S Pendergrast; N Hernandez
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

6.  Detecting Sources of Immune Activation and Viral Rebound in HIV Infection.

Authors:  Stephen W Wietgrefe; Lijie Duan; Jodi Anderson; Guillermo Marqués; Mark Sanders; Nathan W Cummins; Andrew D Badley; Curtis Dobrowolski; Jonathan Karn; Amélie Pagliuzza; Nicolas Chomont; Gérémy Sannier; Mathieu Dubé; Daniel E Kaufmann; Paul Zuck; Guoxin Wu; Bonnie J Howell; Cavan Reilly; Alon Herschhorn; Timothy W Schacker; Ashley T Haase
Journal:  J Virol       Date:  2022-07-20       Impact factor: 6.549

7.  Constant mean viral copy number per infected cell in tissues regardless of high, low, or undetectable plasma HIV RNA.

Authors:  R D Hockett; J M Kilby; C A Derdeyn; M S Saag; M Sillers; K Squires; S Chiz; M A Nowak; G M Shaw; R P Bucy
Journal:  J Exp Med       Date:  1999-05-17       Impact factor: 14.307

8.  A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals.

Authors:  Francesco Andrea Procopio; Rémi Fromentin; Deanna A Kulpa; Jessica H Brehm; Anne-Gaelle Bebin; Matthew C Strain; Douglas D Richman; Una O'Doherty; Sarah Palmer; Frederick M Hecht; Rebecca Hoh; Richard J O Barnard; Michael D Miller; Daria J Hazuda; Steven G Deeks; Rafick-Pierre Sékaly; Nicolas Chomont
Journal:  EBioMedicine       Date:  2015-06-27       Impact factor: 8.143

9.  Combined single-cell quantitation of host and SIV genes and proteins ex vivo reveals host-pathogen interactions in individual cells.

Authors:  Diane L Bolton; Kathleen McGinnis; Greg Finak; Pratip Chattopadhyay; Raphael Gottardo; Mario Roederer
Journal:  PLoS Pathog       Date:  2017-06-27       Impact factor: 6.823

10.  The HIV-1 Rev protein enhances encapsidation of unspliced and spliced, RRE-containing lentiviral vector RNA.

Authors:  Bastian Grewe; Katrin Ehrhardt; Bianca Hoffmann; Maik Blissenbach; Sabine Brandt; Klaus Uberla
Journal:  PLoS One       Date:  2012-11-01       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.